.
Raay Neo Pharma on Saturday announced the launch of its operations in Lucknow as part of its expansion strategy focused on Uttar Pradesh and other fast-growing healthcare markets in north and central India.The pharmaceutical company said it plans to strengthen access to affordable medicines and healthcare delivery across Tier II and Tier III cities, positioning Lucknow as a key centre for its north India operations.The announcement was made during a press conference in Lucknow, where the company outlined its regional growth plans and healthcare strategy.Raay Neo Pharma said it will introduce a portfolio of more than 90 formulations covering both acute and chronic therapies. The portfolio includes medicines for antibiotics, diabetes care, gastro-intestinal disorders, pain and orthopaedic treatment, respiratory and allergy care, cardiac therapy, and dermatology.The company said it is also developing additional advanced formulations as part of its future pipeline.Founder Amit Patni said Lucknow serves as a major healthcare and referral hub for Uttar Pradesh and neighbouring states, with patients from smaller cities and towns depending on the city for specialised treatment. “Lucknow is an important healthcare hub not only for Uttar Pradesh, but for a much larger patient ecosystem across this geography. The region continues to witness growing healthcare needs, particularly around chronic disease management, affordability, and continuity of treatment,” Patni said.The company said it is expanding its presence across Uttar Pradesh, Bihar, Madhya Pradesh and Delhi-NCR, along with other high-growth healthcare markets.Raay Neo Pharma said it will operate through a mix of in-house capabilities and strategic manufacturing partnerships to scale operations while maintaining quality and compliance standards.
